Youth Suicide Screening Pathway
Suicide risk screening is especially challenging. Although data are not yet available to ascertain how COVID-19 will affect the suicide rate, the 3-tiered clinical pathway has been revised to accommodate mostly telehealth screening.
Suicide risk screening is especially challenging in the time of a pandemic. Data are not yet available to ascertain how COVID-19 will affect the suicide rate. However, the 3-tiered clinical pathway needed to be revised to accommodate mostly telehealth screening. Maryland Pao, MD, Annabelle M. Mournet, and Lisa M. Horowitz, PhD, MPH, revised the suicide risk screening clinical pathways published by Brahmbhatt and colleagues to reflect the need for phone screening and assessments.
Learn more in the article "Implementation Challenges of Universal Suicide Risk Screening in Adult Patients in General Medical and Surgical Settings," to appear in the July 2020 issue of Psychiatric Times. [link TBA]
Courtesy: National Institute of Mental Health
